Position in FLGT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,018,983
-$2,029,597 QoQ
Shares Held
64,087
-44.8% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
8 quarters on record
Voting authority
Sole 50.ToString("F0")%
Shared 50.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FLGT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026TUDOR INVESTMENT CORP ET AL holds $196,413,250 across 21 Diagnostics & Research names. FLGT ranks #15 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
447,231 | $84,794,997 | |
| 2 | NTRA |
Natera, Inc.
|
150,693 | $30,137,093 | |
| 3 | A |
Agilent Technologies, Inc.
|
159,699 | $18,202,492 | |
| 4 | SHC |
Sotera Health Co
|
845,120 | $12,119,020 | |
| 5 | ADPT |
Adaptive Biotechnologies Corp
|
786,281 | $10,913,580 | |
| 6 | ICLR |
Icon PLC
|
65,375 | $7,234,397 | |
| 7 | TMO |
Thermo Fisher Scientific Inc.
|
13,534 | $6,652,367 | |
| 8 | CSTL |
Castle Biosciences Inc
|
222,982 | $5,474,208 |
All Filings in FLGT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,018,983 | 64,087 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,048,580 | 116,048 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,875,787 | 171,495 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,679,549 | 185,088 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $805,944 | 47,689 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $369,801 | 17,018 | Shares | Defined | 2024-11-14 | |
| 2021-12-31 | $571,451 | 5,681 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $524,594 | 10,069 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||